1.30犀牛财经晚报：国际贵金属遭资金全面抛售

Group 1: Precious Metals Market - International gold and silver prices experienced a sharp decline, with spot gold dropping by 7.95% to $4949.62 per ounce and spot silver falling by 16.93% to $95.86 per ounce, hitting a low of $95 [1] - The market volatility was attributed to speculation and a sudden sell-off, with gold prices plummeting by $380 in just 28 minutes, a nearly 7% drop, while silver prices fell by 11% in the same timeframe [3] - The World Gold Council reported that the demand for gold in 2025 is expected to solidify its position among central banks, investors, and consumers, with structural adjustments impacting the market until early 2026 [3] Group 2: Lithium Mining Sector - The lithium mining sector faced a significant drop, but companies like Ganfeng Lithium and Yahua Group reported that their operations are normal and products are in high demand [2] - Battery-grade lithium carbonate prices have surged from approximately 70,000 yuan per ton to around 170,000 yuan per ton since the second half of 2025, indicating a recovery that may benefit companies with their own mines and salt lakes [2] Group 3: Private Equity and IPOs - In January, private equity firms participated in new stock placements, with a total allocation amounting to 338 million yuan across five companies, highlighting the continued interest in private equity investments [4] - The China Securities Regulatory Commission approved the IPO registration of Beijing Weitongli Electric Co., indicating ongoing activity in the public market [7] Group 4: Renewable Energy and Hydrogen Production - By the end of 2025, China's renewable energy hydrogen production capacity is expected to exceed 250,000 tons per year, marking a significant increase compared to the previous year [6] Group 5: Chicken Market - The white feather chicken market has shown signs of recovery, with prices for large wings nearing 50 yuan per kilogram, reflecting a more than 20% increase from the low point in October 2025 [6] Group 6: Pharmaceutical Developments - Kangzheng Pharmaceutical received approval for the first targeted drug for treating vitiligo in China, indicating advancements in the pharmaceutical sector [5] Group 7: Financial Performance Forecasts - Companies such as CICC and Huazi Industrial are projecting significant profit increases for 2025, with CICC expecting a net profit increase of 50% to 85% and Huazi Industrial forecasting a growth of 128% to 167% [16][18]